Clinical trials
Phase 1 Prostatic Hyperplasia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
60 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 6 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 12 |
| 2016 | 2 |
| 2017 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 46 |
| Unknown status | 5 |
| Not yet recruiting | 3 |
| Recruiting | 3 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 13 |
| Chong Kun Dang Pharmaceutical | 6 |
| Addpharma Inc. | 4 |
| Hanmi Pharmaceutical Company Limited | 3 |
| Jeil Pharmaceutical Co., Ltd. | 3 |
| Benha University | 2 |
| Boehringer Ingelheim | 2 |
| Dongkook Pharmaceutical Co., Ltd. | 2 |
| Yuyu Pharma, Inc. | 2 |
| Assiut University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Hyperplasia | 60 |
| Lower Urinary Tract Symptoms | 6 |
| Urinary Bladder, Overactive | 6 |
| Erectile Dysfunction | 4 |
| Prostatic Neoplasms | 2 |
| Urinary Bladder Neck Obstruction | 2 |
| Genital Diseases, Male | 1 |
| Male Urogenital Diseases | 1 |
| Nocturia | 1 |
| Prostatic Diseases | 1 |
Trials
Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.